10 Results for "

BRD4-BD1-IN-4

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "BRD4-BD1-IN-4" in MCE Product Catalog:

Cat. No.: HY-187207
BRD4-BD1-IN-4 is a selective BRD4 BD1 inhibitor with an IC50 of 0.82 μM and a Kd of 0.98 μM. BRD4-BD1-IN-4 downregulates the expression of c-myc and anti-apoptotic proteins, elevates ROS levels, reduces mitochondrial membrane potential, induces DNA damage and triggers apoptosis. BRD4-BD1-IN-4 inhibits the migration and proliferation of cancer cells. BRD4-BD1-IN-4 can be used in the research of lung cancer, breast cancer and colon cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-120000
CAS No.: 1672684-68-2
Purity:  99.62%
Research Areas:  

Inflammation/Immunology Cancer

MS402 is a BD1-selective BET BrD inhibitor with Kis of 77 nM, 718 nM, 110 nM, 200 nM, 83 nM, and 240 nM for BRD4(BD1), BRD4(BD2), BRD3(BD1), BRD3(BD2), BRD2(BD1) and BRD2(BD2), respectively. MS402 blocks Th17 cell differentiation and ameliorates colitis in mice .
loading...
    loading...
Cat. No.: HY-178041
CAS No.: 3106588-54-6
BRD4-BD1/2-IN-3 (Compound B6) is a selective BRD4 BD2 inhibitor with an IC50 of 0.41  nM for BRD4 BD2 over BRD4 BD1. BRD4-BD1/2-IN-3 significantly inhibits the LPS (HY-D1056)-induced expression of IL-6. BRD4-BD1/2-IN-3 shows anti-inflammatory activities by modulating the TNF and NF-κB signaling pathway. BRD4-BD1/2-IN-3 can be used for inflammatory diseases research .
loading...
    loading...
Cat. No.: HY-146739
CAS No.: 2757865-63-5
Research Areas:  

Cancer

BRD4 Inhibitor-19 is a BET inhibitor with an IC50 of 55 nM for BRD4-BD1. BRD4 Inhibitor-19 can be used for multiple myeloma research .
loading...
    loading...
Cat. No.: HY-111977
CAS No.: 1952264-34-4
Purity:  99.75%
Research Areas:  

Cancer

ZEN-3219 is a BET inhibitor with IC50s of 0.48, 0.16 and 0.47 μM for BRD4(BD1), BRD4(BD2) and BRD4(BD1BD2), respectively. ZEN-3219 can be used to form PROTACs to induce degradation of BRD4 .
loading...
    loading...
Cat. No.: HY-111979
CAS No.: 1952264-36-6
Research Areas:  

Cancer

ZEN-3411 is a BET inhibitor with IC50s of 0.05, 0.05 and 0.06 μM for BRD4(BD1), BRD4(BD2) and BRD4(BD1BD2), respectively. ZEN-3411 can be used to form PROTACs to induce degradation of BRD4 .
loading...
    loading...
Cat. No.: HY-129201
CAS No.: 1616400-50-0
Purity:  99.51%
Research Areas:  

Cancer

ZEN-2759 is a potent BET (Bromodomain and Extra-Terminal Domain) inhibitor, with IC50 values of 0.23, 0.08 and 0.28 μM for BRD4(BD1), BRD4(BD2), and BRD4(BD1BD2), respectively .
loading...
    loading...
Cat. No.: HY-153945
CAS No.: 2408994-22-7
Research Areas:  

Cancer

BET-IN-15 (compound 1) is a potent and orally active BET inhibitor with IC50 values of 0.64,0.25 nM for BRD4-BD1,BRD4-BD2,respectively. BET-IN-15 shows antiproliferative activity .
loading...
    loading...
Cat. No.: HY-173062
CAS No.: 2994635-04-8
Research Areas:  

Others

BRD4 Inhibitor-40 (Compound 23) is the inhibitor for BRD that inhibits BRD4-BD1, BRD4-BD2, BRD2-BD1 and BRD2-BD2 with IC50s of 16.1, 142.18, 29.35 and 302.35 nM, respectively. BRD4 Inhibitor-40 modulates the expression of c-Myc and p21, arrests cell cycle at G1 phase, inhibits Pkd1-null (PN) renal cystic epithelial cells, and blocks the renal cysts formation in Madin-Darby canine kidney and embryonic kidney vesicle models. BRD4 Inhibitor-40 exhibits renal cysts inhibitory activity in mouse models .
loading...
    loading...
Cat. No.: HY-111977R
CAS No.: 1952264-34-4
Research Areas:  

Cancer

ZEN-3219 (Standard) is the analytical standard of ZEN-3219 (HY-111977). This product is intended for research and analytical applications. ZEN-3219 is a BET inhibitor with IC50s of 0.48, 0.16 and 0.47 μM for BRD4(BD1), BRD4(BD2) and BRD4(BD1BD2), respectively. ZEN-3219 can be used to form PROTACs to induce degradation of BRD4 .
loading...
    loading...